TITLE

Non-Hemodynamic Effects of Organic Nitrates and the Distinctive Characteristics of Pentaerithrityl Tetranitrate

AUTHOR(S)
Gori, Tommaso; Daiber, Andreas
PUB. DATE
January 2009
SOURCE
American Journal of Cardiovascular Drugs;2009, Vol. 9 Issue 1, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Organic nitrates are among the oldest and yet most commonly employed drugs in the long-term therapy of coronary artery disease and congestive heart failure. While they have long been used in clinical practice, our understanding of their mechanism of action and side effects remains incomplete. For instance, recent findings provide evidence of previously unanticipated, non-hemodynamic properties that include potentially beneficial mechanisms (such as the induction of a protective phenotype that mimics ischemic preconditioning), but also toxic effects (such as endothelial and autonomic dysfunction, rebound angina, tolerance). To date, the most commonly employed organic nitrates are isosorbide mononitrate, isosorbide dinitrate, and nitroglycerin (glyceryl trinitrate). Another organic nitrate, pentaerithrityl tetranitrate (PETN), has long been employed in eastern European countries and is currently being reintroduced in Western countries. In light of their wide use, and of the (re)introduction of PETN in Western markets, the present review focuses on the novel effects of organic nitrates, describing their potential clinical implications and discussing differences among different compounds.We believe that these recent findings have important clinical implications. Since the side effects of organic nitrates such as nitroglycerin and isosorbides appear to be mediated by reactive oxygen species, care should be taken that drugs with antioxidant properties are co-administered. On the other hand, efforts should be made to clinically exploit the preconditioning effects of these drugs.
ACCESSION #
38416487

 

Related Articles

  • Carvedilol has a beneficial effect on left ventricular remodeling.  // Modern Medicine;Jul97, Vol. 65 Issue 7, p54 

    Presents an abstract of the study `Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease,' by R.N. Doughty, G.A. Whalley, G. Gamble et al published in the April 1997 issue of the `Journal of the American College of Cardiology.'

  • Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US. Rosen, Virginia M.; Taylor, Douglas C. A.; Parekh, Hemangi; Pandya, Ankur; Thompson, David; Kuznik, Andreas; Waters, David D.; Drummond, Michael; Weinstein, Milton C. // PharmacoEconomics;2010, Vol. 28 Issue 1, p47 

    Background: A recent study found fewer hospitalizations for congestive heart failure (CHF) patients receiving high-dose versus low-dose statin therapy. Objective: To examine the cost effectiveness of high-dose versus low-dose statin therapy in CHF patients. Methods: Two scenarios...

  • Safety and Feasibility of Coronary Stenting in Unprotected Left Main Coronary Artery Disease in the Real World Clinical Practice—A Single Center Experience. Lee, Wei-Chieh; Tsai, Tzu-Hsien; Chen, Yung-Lung; Yang, Cheng-Hsu; Chen, Shyh-Ming; Chen, Chien-Jen; Lin, Cheng-Jei; Cheng, Cheng-I; Hang, Chi-Ling; Wu, Chiung-Jen; Yip, Hon-Kan // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: This study evaluated the feasibility, safety, and prognostic outcome in patients with significant unprotected left main coronary artery (ULMCA) disease undergoing stenting. Method and Results: Between January 2010 and December 2012, totally 309 patients, including those with stable...

  • Aspirin for unstable angina? Petch, M.C. // British Medical Journal (Clinical Research Edition);7/5/1986, Vol. 293 Issue 6538, p1 

    Examines the effectiveness of aspirin on unstable angina. Angiographic pattern of coronay artery disease in patients with unstable angina; Occurrence of the disease; Reduction of risk of subsequent cardiac events in patients.

  • Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Jordan, Randy A.; Seth, Love; Casebolt, Penny; Hayes, Michael J.; Wilen, Mary M.; Franciosa, Joseph; Jordan, R A; Seth, L; Casebolt, P; Hayes, M J; Wilen, M M; Franciosa, J // Annals of Internal Medicine;Mar1986, Vol. 104 Issue 3, p295 

    We have reported early attenuation of hemodynamic effects of transdermal nitroglycerin in patients with heart failure. We now report nitroglycerin plasma levels in those same patients. We administered transdermal nitroglycerin, 60 mg/24 h, to eight patients or placebo to seven patients in a...

  • Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats. Sarbishegi, Maryam; Heidari, Zahra; Sagheb, Hamidreza Mahmoudzadeh; Valizadeh, Moharram; Doostkami, Mahboobeh // Avicenna Journal of Phytomedicine;Jun2016, Vol. 6 Issue 4, p399 

    Objective: Oxygen free radicals may be implicated in the pathogenesis of ischemia reperfusion damage. The beneficial effects of antioxidant nutrients, as well as complex plant extracts, on cerebral ischemia-reperfusion injuries are well known. This study was conducted to determine the effects of...

  • Oral nitrate preparations: An update. Bomber, Jeffrey W.; De Tullio, Pamela L. // American Family Physician;12/1/1995, Vol. 52 Issue 8, p2331 

    Discusses various aspects of oral nitrate preparations in the United States as treatment for angina and congestive heart failure. Mechanisms of actions of oral nitrates; Preparations, dosage and administration; Dosing regimens; Pharmacokinetics; Tolerance; Adverse effects.

  • Safety and efficacy of first line antihypertensives. Strickland, Carmen // Journal of Family Practice;Jun1997, Vol. 44 Issue 6, p530 

    The article discusses research being done on antihypertensive therapy, with reference to a study by B. M. Psaty, N. L. Smith, D. S. Siscovick et al., which appeared in the 1997 issue of the "Journal of the American Medical Association." Trials of first-line antihypertensive therapy from a...

  • New and Emerging Drug Molecules Against Obesity. George, Melvin; Rajaram, Muthukumar; Shanmugam, Elangovan // Journal of Cardiovascular Pharmacology & Therapeutics;Jan2014, Vol. 19 Issue 1, p65 

    Obesity has become a growing pandemic of alarming proportions in the developed and developing countries over the last few decades. The most perturbing fact regarding obesity is the increased predisposition for coronary artery disease, congestive heart failure and sudden cardiac death. The modest...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics